Progression of chronic kidney disease: too much cellular talk causes damage

Kidney International

Volumn 91, Issue 3, 2017, Pages 552-560

  Gewin, Leslie ^a,b   Zent, Roy ^a,b   Pozzi, Ambra ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

endothelial cells; epithelial cells; fibroblasts; fibrosis; inflammation; interstitium

Indexed keywords

CYTOKINE; GROWTH FACTOR;

CELL ACTIVATION; CELL COMMUNICATION; CELL CYCLE; CELL INTERACTION; CELL LOSS; CELL MIGRATION; CHRONIC KIDNEY FAILURE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; INFLAMMATORY CELL; KIDNEY BLOOD VESSEL; KIDNEY FIBROSIS; KIDNEY TUBULE DAMAGE; NONHUMAN; PATHOGENESIS; PERICYTE; RECURRENT DISEASE; SHORT SURVEY; ANIMAL; FIBROSIS; IMMUNOLOGY; KIDNEY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMMUNICATION; CYTOKINES; FIBROSIS; HUMANS; KIDNEY; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION;

EID: 85008953587     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.08.025     Document Type: Short Survey

References (106)

1. 1 Zhou, Y., Fang, L., Yu, Y., et al. Erythropoietin protects the tubular basement membrane by promoting the bone marrow to release extracellular vesicles containing tPA-targeting miR-144. Am J Physiol Renal Physiol 310 (2016), F27–F40.
2. 2 Ishibe, S., Cantley, L.G., Epithelial-mesenchymal-epithelial cycling in kidney repair. Curr Opin Nephrol Hypertens 17 (2008), 379–385.
3. 3 Grgic, I., Campanholle, G., Bijol, V., et al. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int 82 (2012), 172–183.
4. 4 Schelling, J.R., Tubular atrophy in the pathogenesis of chronic kidney disease progression. Pediatr Nephrol 31 (2016), 693–706.
5. 5 Iwano, M., Plieth, D., Danoff, T.M., et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110 (2002), 341–350.
6. 6 Zeisberg, M., Hanai, J., Sugimoto, H., et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9 (2003), 964–968.
7. 7 Higgins, D.F., Kimura, K., Bernhardt, W.M., et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 117 (2007), 3810–3820.
8. 8 Li, Y., Yang, J., Dai, C., et al. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 112 (2003), 503–516.
9. 9 Lebleu, V.S., Taduri, G., O'Connell, J., et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19 (2013), 1047–1053.
10. 10 Asada, N., Takase, M., Nakamura, J., et al. Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J Clin Invest 121 (2011), 3981–3990.
11. 11 Humphreys, B.D., Lin, S.L., Kobayashi, A., et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176 (2010), 85–97.
12. 12 Grande, M.T., Sanchez-Laorden, B., Lopez-Blau, C., et al. Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med 21 (2015), 989–997.
13. 13 Lovisa, S., LeBleu, V.S., Tampe, B., et al. Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med 21 (2015), 998–1009.
14. 14 Yang, L., Besschetnova, T.Y., Brooks, C.R., et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16 (2010), 535–543 1p following 143.
15. 15 Kaissling, B., Le Hir, M., The renal cortical interstitium: morphological and functional aspects. Histochem Cell Biol 130 (2008), 247–262.
16. 16 Neelisetty, S., Alford, C., Reynolds, K., et al. Renal fibrosis is not reduced by blocking transforming growth factor-beta signaling in matrix-producing interstitial cells. Kidney Int 88 (2015), 503–514.
17. 17 Sun, K.H., Chang, Y., Reed, N.I., Sheppard, D., α-Smooth muscle actin is an inconsistent marker of fibroblasts responsible for force dependent TGFβ activation or collagen production across multiple models of organ fibrosis. Am J Physiol Lung Cell Mol Physiol 310 (2016), L824–L836.
18. 18 Fujigaki, Y., Muranaka, Y., Sun, D., et al. Transient myofibroblast differentiation of interstitial fibroblastic cells relevant to tubular dilatation in uranyl acetate-induced acute renal failure in rats. Virchows Arch 446 (2005), 164–176.
19. 19 Demehri, S., Turkoz, A., Kopan, R., Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. Cancer Cell 16 (2009), 55–66.
20. 20 Matise, L.A., Palmer, T.D., Ashby, W.J., et al. Lack of transforming growth factor-beta signaling promotes collective cancer cell invasion through tumor-stromal crosstalk. Breast Cancer Res, 14, 2012, R98.
21. 21 Combes, A.N., Davies, J.A., Little, M.H., Cell-cell interactions driving kidney morphogenesis. Curr Top Dev Biol 112 (2015), 467–508.
22. 22 Edeling, M., Ragi, G., Huang, S., et al. Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog. Nat Rev Nephrol 12 (2016), 426–439.
23. 23 Desmouliere, A., Geinoz, A., Gabbiani, F., et al. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122 (1993), 103–111.
24. 24 Ignotz, R.A., Endo, T., Massague, J., Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem 262 (1987), 6443–6446.
25. 25 Roberts, A.B., Sporn, M.B., Assoian, R.K., et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 83 (1986), 4167–4171.
26. 26 Wu, C.F., Chiang, W.C., Lai, C.F., et al. Transforming growth factor beta-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis. Am J Pathol 182 (2013), 118–131.
27. 27 Ma, L.J., Yang, H., Gaspert, A., et al. Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice. Am J Pathol 163 (2003), 1261–1273.
28. 28 Munger, J.S., Huang, X., Kawakatsu, H., et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96 (1999), 319–328.
29. 29 Borges, F.T., Melo, S.A., Ozdemir, B.C., et al. TGF-beta1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J Am Soc Nephrol 24 (2013), 385–392.
30. 30 Koesters, R., Kaissling, B., Lehir, M., et al. Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 177 (2010), 632–643.
31. 31 Geng, H., Lan, R., Singha, P.K., et al. Lysophosphatidic acid increases proximal tubule cell secretion of profibrotic cytokines PDGF-B and CTGF through LPA2- and Galphaq-mediated Rho and alphavbeta6 integrin-dependent activation of TGF-beta. Am J Pathol 181 (2012), 1236–1249.
32. 32 Breyer, M.D., Susztak, K., The next generation of therapeutics for chronic kidney disease. Nat Rev Drug Discov 15 (2016), 568–588.
33. 33 Voelker J, Berg PH, Sheetz M, et al. Anti-TGF-ß1 antibody therapy in patients with diabetic nephropathy [e-pub ahead of print]. J Am Soc Nephrol. pii: ASN.2015111230. Accessed October 2, 2016.
34. 34 Kimura, M., Asano, M., Abe, K., et al. Role of atrophic changes in proximal tubular cells in the peritubular deposition of type IV collagen in a rat renal ablation model. Nephrol Dial Transplant 20 (2005), 1559–1565.
35. 35 Tang, W.W., Ulich, T.R., Lacey, D.L., et al. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 148 (1996), 1169–1180.
36. 36 Suzuki, T., Kimura, M., Asano, M., et al. Role of atrophic tubules in development of interstitial fibrosis in microembolism-induced renal failure in rat. Am J Pathol 158 (2001), 75–85.
37. 37 Chen, Y.T., Chang, F.C., Wu, C.F., et al. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int 80 (2011), 1170–1181.
38. 38 Seifert, R.A., Alpers, C.E., Bowen-Pope, D.F., Expression of platelet-derived growth factor and its receptors in the developing and adult mouse kidney. Kidney Int 54 (1998), 731–746.
39. 39 Kliem, V., Johnson, R.J., Alpers, C.E., et al. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 49 (1996), 666–678.
40. 40 Fabian, S.L., Penchev, R.R., St-Jacques, B., et al. Hedgehog-Gli pathway activation during kidney fibrosis. Am J Pathol 180 (2012), 1441–1453.
41. 41 Ding, H., Zhou, D., Hao, S., et al. Sonic hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis. J Am Soc Nephrol 23 (2012), 801–813.
42. 42 Zhou, D., Li, Y., Zhou, L., et al. Sonic hedgehog is a novel tubule-derived growth factor for interstitial fibroblasts after kidney injury. J Am Soc Nephrol 25 (2014), 2187–2200.
43. 43 Villegas, V.E., Rahman, M.F., Fernandez-Barrena, M.G., et al. Identification of novel non-coding RNA-based negative feedback regulating the expression of the oncogenic transcription factor GLI1. Mol Oncol 8 (2014), 912–926.
44. 44 Kramann, R., Fleig, S.V., Schneider, R.K., et al. Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis. J Clin Invest 125 (2015), 2935–2951.
45. 45 Kramann, R., Dirocco, D.P., Maarouf, O.H., et al. Matrix producing cells in chronic kidney disease: origin, regulation, and activation. Curr Pathobiol Rep, 1(4), 2013.
46. 46 Kang, H.M., Huang, S., Reidy, K., et al. Sox9-positive progenitor cells play a key role in renal tubule epithelial regeneration in mice. Cell Rep 14 (2016), 861–871.
47. 47 Kawakami, T., Ren, S., Duffield, J.S., Wnt signalling in kidney diseases: dual roles in renal injury and repair. J Pathol 229 (2013), 221–231.
48. 48 He, W., Dai, C., Li, Y., et al. Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 20 (2009), 765–776.
49. 49 Saito, S., Tampe, B., Muller, G.A., et al. Primary cilia modulate balance of canonical and non-canonical Wnt signaling responses in the injured kidney. Fibrogenesis Tissue Repair, 8, 2015, 6.
50. 50 Maarouf, O.H., Aravamudhan, A., Rangarajan, D., et al. Paracrine Wnt1 drives interstitial fibrosis without inflammation by tubulointerstitial cross-talk. J Am Soc Nephrol 27 (2016), 781–790.
51. 51 DiRocco, D.P., Kobayashi, A., Taketo, M.M., et al. Wnt4/beta-catenin signaling in medullary kidney myofibroblasts. J Am Soc Nephrol 24 (2013), 1399–1412.
52. 52 Zhou, D., Tan, R.J., Zhou, L., et al. Kidney tubular beta-catenin signaling controls interstitial fibroblast fate via epithelial-mesenchymal communication. Sci Rep, 3, 2013, 1878.
53. 53 Bienaimé F, Muorah M, Yammine L, et al. Stat3 controls tubulointerstitial communication during CKD [e-pub ahead of print]. J Am Soc Nephrol. pii: ASN.2015091014. Accessed May 6, 2016.
54. 54 Berthier, C.C., Zhang, H., Schin, M., et al. Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes 58 (2009), 469–477.
55. 55 Lu, Y., Liu, S., Zhang, S., et al. Tissue inhibitor of metalloproteinase-1 promotes NIH3T3 fibroblast proliferation by activating p-Akt and cell cycle progression. Mol Cells 31 (2011), 225–230.
56. 56 Lovelock, J.D., Baker, A.H., Gao, F., et al. Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts. Am J Physiol Heart Circ Physiol 288 (2005), H461–H468.
57. 57 Tarjus, A., Martinez-Martinez, E., Amador, C., et al. Neutrophil gelatinase-associated lipocalin, a novel mineralocorticoid biotarget, mediates vascular profibrotic effects of mineralocorticoids. Hypertension 66 (2015), 158–166.
58. 58 Duffield JS. Beyond EMT: epithelial STAT3 as a central regulator of fibrogenesis [e-pub ahead of print]. J Am Soc Nephrol. pii: ASN.2016060603. Accessed July 1, 2016.
59. 59 Harris, R.C., Chung, E., Coffey, R.J., EGF receptor ligands. Exp Cell Res 284 (2003), 2–13.
60. 60 Yen, T.H., Alison, M.R., Goodlad, R.A., et al. Epidermal growth factor attenuates tubular necrosis following mercuric chloride damage by regeneration of indigenous, not bone marrow-derived cells. J Cell Mol Med 19 (2015), 463–473.
61. 61 Wang, Z., Chen, J.K., Wang, S.W., et al. Importance of functional EGF receptors in recovery from acute nephrotoxic injury. J Am Soc Nephrol 14 (2003), 3147–3154.
62. 62 Chen, J., Chen, J.K., Harris, R.C., Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury. Kidney Int 82 (2012), 45–52.
63. 63 Chen, J., Chen, J.K., Nagai, K., et al. EGFR signaling promotes TGFbeta-dependent renal fibrosis. J Am Soc Nephrol 23 (2012), 215–224.
64. 64 Liu, N., Guo, J.K., Pang, M., et al. Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis. J Am Soc Nephrol 23 (2012), 854–867.
65. 65 Tang, J., Liu, N., Tolbert, E., et al. Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury. Am J Pathol 183 (2013), 160–172.
66. 66 Ju, W., Nair, V., Smith, S., et al. Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. Sci Transl Med, 7, 2015, 316ra193.
67. 67 Nakopoulou, L., Stefanaki, K., Boletis, J., et al. Immunohistochemical study of epidermal growth factor receptor (EGFR) in various types of renal injury. Nephrol Dial Transplant 9 (1994), 764–769.
68. 68 Sis, B., Sarioglu, S., Celik, A., et al. Epidermal growth factor receptor expression in human renal allograft biopsies: an immunohistochemical study. Transpl Immunol 13 (2004), 229–232.
69. 69 Kok, H.M., Falke, L.L., Goldschmeding, R., et al. Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease. Nat Rev Nephrol 10 (2014), 700–711.
70. 70 Bielesz, B., Sirin, Y., Si, H., et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 120 (2010), 4040–4054.
71. 71 Rogers, N.M., Ferenbach, D.A., Isenberg, J.S., et al. Dendritic cells and macrophages in the kidney: a spectrum of good and evil. Nat Rev Nephrol 10 (2014), 625–643.
72. 72 Gottschalk, C., Kurts, C., The debate about dendritic cells and macrophages in the kidney. Front Immunol, 6, 2015, 435.
73. 73 Eardley, K.S., Kubal, C., Zehnder, D., et al. The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease. Kidney Int 74 (2008), 495–504.
74. 74 Morrissey, J.J., Klahr, S., Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis. Am J Physiol 274 (1998), F580–F586.
75. 75 Prodjosudjadi, W., Gerritsma, J.S., Klar-Mohamad, N., et al. Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int 48 (1995), 1477–1486.
76. 76 Lai, K.N., Leung, J.C., Chan, L.Y., et al. Interaction between proximal tubular epithelial cells and infiltrating monocytes/T cells in the proteinuric state. Kidney Int 71 (2007), 526–538.
77. 77 Prodjosudjadi, W., Gerritsma, J.S., van Es, L.A., et al. Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. Clin Nephrol 44 (1995), 148–155.
78. 78 Segerer, S., Mac, K.M., Regele, H., et al. Expression of the C-C chemokine receptor 5 in human kidney diseases. Kidney Int 56 (1999), 52–64.
79. 79 Isbel, N.M., Hill, P.A., Foti, R., et al. Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation. Kidney Int 60 (2001), 614–625.
80. 80 Wang, Y., Chang, J., Yao, B., et al. Proximal tubule-derived colony stimulating factor-1 mediates polarization of renal macrophages and dendritic cells, and recovery in acute kidney injury. Kidney Int 88 (2015), 1274–1282.
81. 81 Zhang, M.Z., Yao, B., Yang, S., et al. CSF-1 signaling mediates recovery from acute kidney injury. J Clin Invest 122 (2012), 4519–4532.
82. 82 Peng, X., Zhang, J., Xiao, Z., et al. CX3CL1-CX3CR1 interaction increases the population of Ly6C(-)CX3CR1(hi) macrophages contributing to unilateral ureteral obstruction-induced fibrosis. J Immunol 195 (2015), 2797–2805.
83. 83 Kassianos, A.J., Wang, X., Sampangi, S., et al. Fractalkine-CX3CR1-dependent recruitment and retention of human CD1c+ myeloid dendritic cells by in vitro-activated proximal tubular epithelial cells. Kidney Int 87 (2015), 1153–1163.
84. 84 Lin, S.L., Li, B., Rao, S., et al. Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci U S A 107 (2010), 4194–4199.
85. 85 Vinuesa, E., Hotter, G., Jung, M., et al. Macrophage involvement in the kidney repair phase after ischaemia/reperfusion injury. J Pathol 214 (2008), 104–113.
86. 86 Sung, S.A., Jo, S.K., Cho, W.Y., et al. Reduction of renal fibrosis as a result of liposome encapsulated clodronate induced macrophage depletion after unilateral ureteral obstruction in rats. Nephron Exp Nephrol 105 (2007), e1–e9.
87. 87 Henderson, N.C., Mackinnon, A.C., Farnworth, S.L., et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol 172 (2008), 288–298.
88. 88 Ninichuk, V., Khandoga, A.G., Segerer, S., et al. The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice. Am J Pathol 170 (2007), 1267–1276.
89. 89 Machida, Y., Kitamoto, K., Izumi, Y., et al. Renal fibrosis in murine obstructive nephropathy is attenuated by depletion of monocyte lineage, not dendritic cells. J Pharmacol Sci 114 (2010), 464–473.
90. 90 Kitching, A.R., Dendritic cells in progressive renal disease: some answers, many questions. Nephrol Dial Transplant 29 (2014), 2185–2193.
91. 91 Kang, D.H., Kanellis, J., Hugo, C., et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 13 (2002), 806–816.
92. 92 Kida, Y., Tchao, B.N., Yamaguchi, I., Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease. Pediatr Nephrol 29 (2014), 333–342.
93. 93 Sun, D., Ma, Y., Han, H., et al. Thrombospondin-1 short hairpin RNA suppresses tubulointerstitial fibrosis in the kidney of ureteral obstruction by ameliorating peritubular capillary injury. Kidney Blood Press Res 35 (2012), 35–47.
94. 94 Mayer, G., Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease. Nephrol Dial Transplant 26 (2011), 1132–1137.
95. 95 Ninichuk, V., Gross, O., Segerer, S., et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 70 (2006), 121–129.
96. 96 Kang, D.H., Joly, A.H., Oh, S.W., et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 12 (2001), 1434–1447.
97. 97 Schrijvers, B.F., Flyvbjerg, A., Tilton, R.G., et al. Pathophysiological role of vascular endothelial growth factor in the remnant kidney. Nephron Exp Nephrol 101 (2005), e9–e15.
98. 98 Armulik, A., Abramsson, A., Betsholtz, C., Endothelial/pericyte interactions. Circ Res 97 (2005), 512–523.
99. 99 Carmeliet, P., Ferreira, V., Breier, G., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 (1996), 435–439.
100. 100 Franco, M., Roswall, P., Cortez, E., et al. Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression. Blood 118 (2011), 2906–2917.
101. 101 Lin, S.L., Chang, F.C., Schrimpf, C., et al. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am J Pathol 178 (2011), 911–923.
102. 102 Tsai, Y.C., Chiu, Y.W., Tsai, J.C., et al. Association of angiopoietin-2 with renal outcome in chronic kidney disease. PloS One, 9, 2014, e108862.
103. 103 Ziegler T, Horstkotte J, Schwab C, et al. Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis [e-pub ahead of print]. J Clin Invest. http://dx.doi.org/0.1172/JCI66549. Accessed July 1, 2013.
104. 104 Kim, W., Moon, S.O., Lee, S.Y., et al. COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J Am Soc Nephrol 17 (2006), 2474–2483.
105. 105 Dessapt-Baradez, C., Woolf, A.S., White, K.E., et al. Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease. J Am Soc Nephrol 25 (2014), 33–42.
106. 106 Schrimpf, C., Teebken, O.E., Wilhelmi, M., et al. The role of pericyte detachment in vascular rarefaction. J Vasc Res 51 (2014), 247–258.